Free provider profile
REBECCA SHORT-FRIED, DO
NPI 1801250592
Individual
Psychiatry & Neurology, Psychiatry
Active registration
Save to rep workspaceNPI registry Registry record
Source: CMS NPPES registry, updated continuously. This record was last updated 2023-02-22.
300 TAMAL PLZ STE 180, CORTE MADERA, CA, 94925
628-261-7040
Single practice location
Enumerated 2016-04-08
- — Registration is active in NPPES.
- — Individual clinician record — reachable, but usually not the buyer.
- — Practice phone number is published.
- — Full street address on file for route planning.
- — 2 taxonomies listed — broader service mix.
- — Record last updated 3 years ago.
Medicare Part D prescribing
Source: CMS Medicare Part D Prescribers by Provider, most recent public year.
Part D claims
198
Medicare patients
16
Part D drug cost
$5,859
Brand-name share
Not published
of this prescriber's Part D claims
| Drug | Claims | Medicare cost |
|---|---|---|
| Buspirone Hcl (Buspirone Hcl) | 15 | $416 |
| Lamotrigine (Lamotrigine) | 18 | $324 |
| Dextroamphetamine-Amphet Er (Dextroamphetamine/Amphetamine) | 12 | $320 |
| Fluoxetine Hcl (Fluoxetine Hcl) | 28 | $117 |
| Lorazepam (Lorazepam) | 12 | $79 |
| Eszopiclone (Eszopiclone) | 11 | $51 |
| Paroxetine Hcl (Paroxetine Hcl) | 11 | $49 |
| Escitalopram Oxalate (Escitalopram Oxalate) | 14 | $44 |
Want their full drug mix and peer benchmark? Run the free Part D prescriber lookup.
Spravato (esketamine) Medicare billing
Source: CMS Medicare Part B fee-for-service, HCPCS G2082/G2083.
202463 sessions · 11 patients · $83,071
Full Spravato label-compliance detail — sessions per patient against the FDA label, risk flags and year-over-year trend.
- Registry data comes straight from CMS NPPES, which lists registration, not activity — a listed practice may have moved or closed.
- Part D covers Medicare prescription drug enrollees only. Commercial, Medicaid and cash-pay prescribing is not included, so these figures are a floor on real volume, not the whole picture.
- CMS publishes the Part D file annually, roughly two years behind the prescribing year. Drugs with 10 or fewer claims are suppressed.